David Roberts Unloaded $147,257 Worth of LeMaitre Vascular Inc (NASDAQ:LMAT) Shares

Share with your friends


David Roberts Unloaded $147257 Worth of LeMaitre Vascular Shares-Transactions

David Roberts Insider Sell Transaction

It was shown in a legally required report that’s filled with the Security Exchange Commission that David Roberts, who works for LeMaitre Vascular Inc (NASDAQ:LMAT) , and currently holds the position of President and Director finalized an insider trade on November 20, 2015. David unloaded 10,000 shares of the public firm based on a market price of $14.7 USD per share. As shown in the electronic report available at the SEC website here, the total amount of the trade was $147,257 USD. At present, he has in hand 180,839 shares or 0.91 % of Lemaitre Vascular Inc’s market cap.

Lemaitre Vascular Inc Stock Rating, Sentiment and Fundamentals

Seven equity analysts are expecting Lemaitre Vascular Inc to have earnings-per-share of $0.37 this year. This would give it a 42.43 Price/Earnings ratio. A growth rate year-on-year of less than 14.50% is forecasted.

Rating & Sentiment
PsychSignal Social:SELL
Analysts Rating:BUY
Hedge Funds Sentiment:BUY
Stock Fundamentals
Earnings + FCF Trend:BUY
Sector/Industry Macro:BULLISH
Valuation Models:-
Technical Analysis
ST Trend:UP
MT Trend:UP
LT Trend:UP
OctaFinance Rating*:NEUTRAL

* Read How Our Stock Ratings System Works

In the last 200 days, the Lemaitre Vascular Inc’s share price has seen a fast up move of 108.05 % and is now in a very bullish uptrend. Because our equity time momentum model as displayed on the chart below is favourable, our equity traders can’t rate the stock SELL.

Price Chart of Lemaitre Vascular NASDAQ:LMAT Stock

David Roberts Unloaded $147257 Worth of LeMaitre Vascular Shares-Stock-Price-Chart

Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations

As the great Michael Platt, a stock market legend, shared, best money is made through a combination of technical and fundamental analysis. But as our analysis says, this is not evidently with Lemaitre Vascular Inc.

Hedge Funds Ownership

Latest SEC filings disclose 71 institutional players holded Lemaitre Vascular Inc. The tracked institutional investors and hedge funds have traditionally had a high interest in the company, and that was also the case in Q2 2015. The institutional ownership was 49.16 % of the stock’s outstanding shares. They increased by 550,183 the total shares they hold. As of that quarter these institutional investors owned 8.91 million shares. A total of 8 funds closed their positions in Lemaitre Vascular Inc and 14 reduced their holdings. There were 31 funds that created new positions and 16 funds that added to their positions.

As revealed by SEC’s 13F filings, two institutional holders are very long the firm as its in their Top 10 stock holdings.


Perkins Capital Management Inc had the greatest investment with ownership of 180,805 shares as of Q2 2015 for 1.92% of the fund’s portfolio. Awm Investment Company Inc. is another bullish asset manager having 1.33 million shares of the company or 2.28% of their stocks portfolio. The stock is also 1.51% of the fund’s AUM. Moreover J. Carlo Cannell’s Cannell Capital Llc have 3.01% of their stock portfolio invested in the company’s market cap for 763,265 shares. Longwood Capital Partners Llc revealed it had purchased a stake worth 1.86% of the fund’s stock portfolio in Lemaitre Vascular Inc. The Minnesota-based fund First Light Asset Management Llc is also positive in the Massachusetts-based company, possessing 320,768 shares or 1.82% of their stock portfolio.

LeMaitre Vascular NASDAQ:LMAT Company Profile

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. The Company’s product lines include valvulotomes, balloon catheters, carotid shunts, biologic patches, biologic grafts, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, angioscopes and powered phlebectomy devices. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Company Website: LeMaitre Vascular

Lemaitre Vascular Inc was formed in Delaware on 1998-06-15. This company has 325 employees. Now its market value is: $285.69 million and it has 19.85 million shares outstanding. Currently it has 60.65% shareholders and the institutional ownership stands at 60.65%. The stock closed at $15.77 yesterday and it had average 2 days volume of 52827 shares. It is up from the 30 days average shares volume of 34558. Lemaitre Vascular Inc has a one year low of $7.00 and a 52weeks high of $15.99. The stock price is above the 200 days simple moving average. Lemaitre Vascular Inc last issued its quarterly earnings information on 10/27/2015. The company reported 0.11 EPS for the quarter, above the consensus estimate of 0.08 by 0.03. The company had a revenue of 19.03 million for 9/30/2015 and 19.90 million for 6/30/2015. Therefore, the revenue was -872,000 down.

LeMaitre Vascular - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.